Fundamentals of Pharmacology 8e V Pack

$127.99 $139.99
You save 8% ($12.00)
Tax included. Shipping calculated at checkout.

The eighth edition of Fundamentals of Pharmacology presents key scientific and clinical principles to facilitate a greater understanding of pharmacology.

This wholly-Australasian text provides comprehensive and current coverage of topics, written in a clear style with a reader-friendly, full-colour design. The authors have implemented student focused changes to ensure the text is easy to navigate and the content flows to aid comprehension and retention of content.

New to this edition:

  • Book Organisation
    The organisation of the book content has been revised. The Table of Contents has been reduced from 83 chapters in 15 sections in the last edition to 79 chapters in 13 sections in this edition. This change achieves the streamlining of content and focus and should make the text less daunting for students to navigate. We have also removed brand names from the medicine summary tables at the end of most chapters to reinforce the emphasis on medication groupings and generic names.
  • Full colour figures and tables
    Chapter figures are printed in full colour, providing the representations of structures and processes with great depth and vibrancy. Receptors are rendered as G-protein-coupled or ion channels rather than basic geometric shapes. A number of new figures and tables have been included to assist students in visualising difficult pharmacological concepts, the sites of actions of drugs and the range of drug effects expected in a person when particular drug groups are administered. Concept maps linking the pharmacology and pathophysiology are included in this edition and cover the following common conditions: diabetes mellitus, rheumatoid arthritis, asthma, inflammatory bowel disease and ischaemic heart disease.
  • End-of-Chapter and End-of-Section Features
    The book contains over 800 end-of-chapter questions to assist in the consolidation of learning—all of these have been reviewed. New and revised integrated case studies appear at the end of sections to assist with making links between theory and practice.


This edition reflects the availability of medicines in Australia and New Zealand at the time of publication. Consistent with information currently available to us, we have updated new medicines that have entered the marketplace, as well as those that have been removed since the last edition.

Where appropriate, the therapeutic approaches associated with the management of important clinical conditions, such as cardiovascular disease, diabetes mellitus and psychiatric illness have been brought up to date with current clinical guidelines.

Associate Professor Shane Bullock, Monash University, has been involved in the education of student health professionals and scientists for more than 25 years. Shane is the co-author of three Australian textbooks: Fundamentals of Pharmacology, Principles of Pathophysiology and Psychopharmacology for Health Professionals. He has also published a number of journal articles on health professional education, in particular with respect to pharmacology knowledge. He is currently the Director of the Monash School of Rural Health at Churchill, coordinating the first year of the graduate entry medical course.

Professor Elizabeth Manias is a Research Professor within the School of Nursing and Midwifery at Deakin University. Elizabeth is also an Adjunct Professorial Fellow at the Department of Medicine, Royal Melbourne Hospital, The University of Melbourne and an Honorary Professor at the Melbourne School of Health Sciences, The University of Melbourne. She is a registered nurse, a registered pharmacist, a certified geriatric pharmacist and is accredited to undertake Medication Management Reviews. Elizabeth has extensive experience in teaching pharmacology and medication safety to undergraduate and postgraduate students. Her research interests include medication safety, medication adherence, communication processes between health professionals, patients and family members, organisational and environmental aspects associated with patient safety, and consumer participation in care.